Clinical Trials Browser

Phase 4 × INDUSTRY × Sorafenib × Clear all

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase 4 Terminated

Carcinoma, Renal Cell, Neoplasms

NCT01098760 2013-10-31

HATT

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular